Overview
METAFORA biosystems is a health-tech company based in Paris, developing solutions from its single-cell analysis platform.
During ESCCA, we will be showcasing METAflow™, our AI-powered digital flow cytometry software relying on multidimensional clustering, now available for every cytometrist!
METAflow is the only “augmented intelligence” solution allowing users to get quick, objective and reproducible results thanks to its unmatched robustness and a user-friendly interface, whatever their skills, whatever the use case in discovery, development or diagnostics.
METAflow is also supporting proprietary assays developed by METAFORA. These assays stems from a unique reagent platform allowing to measure changes in single-cell metabolism, and determine “cell metabolic fitness” or lack thereof, which is a telltale sign of disease, especially in neurology, cancer and inflammatory diseases. The company has developed METAglut1™, its first IVD test for the early diagnosis of the De Vivo disease, a rare pediatric neurometabolic disorder.